Risk factors for adverse outcome among patients with non-high risk pulmonary embolism
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
https://orcid.org/0000-0003-4105-1915
Abstract
The aim – to determine the factors which have influence on hospital mortality in patients with non-high risk pulmonary embolism (PE).
Materials and methods. We analysed 635 medical cards of patients (pts) with diagnosis «Pulmonary Embolism (PE)» who were hospitalised to Kharkiv City Clinical Hospital No.8. during 01.01.2017 – 01.01.2023. The inclusion criteria was diagnosis «PE» verified by multispiral computed tomography angiography (CTPA) of pulmonary arteries and/or by autopsy. Among the 635 pts, 530 were non-high risk. The non-high risk pts were divided into 2 groups: Group I – pts who were discharged with improved status (479 – 90.4 %), Group II – pts who died during hospitalisation (51 – 9.6 %). Clinical, anamnestic, biochemical, instrumental parameters, mortality rates were measured; statistical analysis was done.
Results and discussion. The independent factors identified by multivariate vector analysis were associated with in-hospital mortality in pts with non-high risk PE: atrial fibrillation (AF), obesity, history of venous thromboembolism (VTE); lower levels of blood oxygen saturation (SpO2), systolic blood pressure (SBP); higher mean pulmonary arterial pressure (PAP); heart rate (HR) ≥ 110 beats/min. An ROC analysis was also performed to determine the thresholds of factors associated with in-hospital mortality in patients with non-high risk PE: SBP ≤ 124 mm Hg, HR ≥ 110 bts/min, mean PAP ≥ 54 mm Hg. Impact of AF on in-hospital mortality was depicted by Kaplan – Meier.
Conclusions. Several factors were associated with increased in-hospital mortality in patients with non-high risk PE: age ˃ 54 years, SBP ≤ 124 mm Hg, history of VTE, obesity, AF; SpO2 ≤ 87 %, mean PAP ≥ 54 mm Hg, HR ≥ 110 bpm.
Article Details
Keywords:
References
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Áinle FN, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J. 2020 21 Jan;41(4):543-603. https://doi.org/10.1093/eurheartj/ehz405.
Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M. Venous throm-boembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost.2007;98(4):756-64. PMID: 17938798.4.
Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O’Connor RE, Ross MA, Shaw LJ. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Nov 30;144(22):e368-e454. https://doi.org/10.1161/CIR.0000000000001029.
Ebner M, Sentler C, Harjola VP, Bueno H, Lerchbaumer MH, Hasenfuß G, Eckardt KU, Konstantinides SV, Lankeit M. Outcome of patients with different clinical presentations of high-risk pulmonary embolism. Eur Heart J Acute Cardiovasc Care. 2021 Oct 1;10(7):787-96. https://doi.org/10.1093/ehjacc/zuab038. PMID: 34125186; PMCID: PMC8483764.
Theroux CD, Aliotta JM, Mullin CJ. High-Risk Pulmonary Embolism: Current Evidence-Based Practices. R I Med J (2013). 2019 Dec 2;102(10):43-7.
Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M. Prognostic models in acute pulmonary embolism: A systematic review and meta-analysis. BMJ Open. 2016 Apr 29;6(4):e010324. https://doi.org/10.1136/bmjopen-2015-010324.
Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005 Oct 15;172(8):1041-6. https://doi.org/10.1164/rccm.200506-862OC.
Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010 Aug 9;170(15):1383-9. https://doi.org/10.1001/archinternmed.2010.199. PMID: 20696966.
Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013 Spring;18(2):129-38. PMID: 23940438; PMCID: PMC3718593
López-Jiménez L, Montero M, González-Fajardo JA, Arcelus JI, Suárez C, Lobo JL, Monreal M; RIETE Investigators. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE). Haematologica. 2006 Aug;91(8):1046-51. PMID: 16885044.
Cash A, Minhas AMK, Pasadyn V, Nazir S, Ariss RW, Gupta R. Trends in pulmonary embolism mortality rates by age group in the United States, 1999–2019, Am Heart J Plus. 2022 Feb 12;13:100103. https://doi.org/10.1016/j.ahjo.2022.100103. eCollection 2022 Jan.
Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020 Apr;93(2):162-168. https://doi.org/10.15386/mpr-1372.
Movahed MR, Khoubyari R, Hashemzadeh M, Hashemzadeh M. Obesity is strongly and independently associated with a higher prevalence of pulmonary embolism, Respir Investig. 2019 Jul;57(4):376-9. https://doi.org/10.1016/j.resinv.2019.01.003.
Keller K, Hobohm L, Münzel T, Ostad MA, Espinola-Klein C, Lavie CJ, Konstantinides S, Lankeit M. Survival Benefit of Obese Patients With Pulmonary Embolism. Mayo Clin Proc. 2019 Oct;94(10):1960-73 https://doi.org/10.1016/j.mayocp.2019.04.035.
Eckelt J, Hobohm L, Merten MC, Pagel CF, Eggers AS, Lerchbaumer MH, Stangl K, Hasenfuß G, Konstantinides S, Schmidtmann I, Lankeit M, Ebner M. Long-term mortality in patients with pulmonary embolism: results in a single-center registry. Res Pract Thromb Haemost. 2023 Jun 14;7(5):100280. https://doi.org/10.1016/j.rpth.2023.100280.
Stein PD, Matta F, Goldman J. Obesity and pulmonary embolism: the mounting evidence of risk and the mortality paradox. Thromb Res. 2011 Dec;128(6):518-23. https://doi.org/10.1016/j.thromres.2011.10.019.
Enga KF, Rye-Holmboe I, Hald EM, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T, Braekkan SK, Hansen JB. Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study. J Thromb Haemost. 2015 Jan;13(1):10-6. https://doi.org/10.1111/jth.12762.
Bikdeli B, Jiménez D, Del Toro J, Piazza G, Rivas A, Fernández-Reyes JL, Sampériz Á, Otero R, Suriñach JM, Siniscalchi C, Martín-Guerra JM, Castro J, Muriel A, Lip GYH, Goldhaber SZ, Monreal M; RIETE Investigators. Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism. J AmHeart Assoc. 2021 Sep 7;10(17):e021467. https://doi.org/10.1161/JAHA.121.021467.
Liu D, Shi S, Liu X, Ye T, Wang L, Qu C, Yang B, Zhao Q. Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis. BMJ Open. 2021 Sep 22;11(9):e047658. https://doi.org/10.1136/bmjopen-2020-047658.
Tseluyko V, Yakovleva L, Askierov R, Kurinna M, Kharchenko L, Shylo N. Risk stratification of poor short-term prognosis in patients with high-risk pulmonary embolism. Emergency medicine. 2023;19(5):361-9. https://doi.org/10.22141/2224-0586.19.5.2023.1612. Ukrainian.
Friberg L, Svennberg E. A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism. Thromb Res. 2020 Nov;195:238-42. https://doi.org/10.1016/j.thromres.2020.08.019.